Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)

Market Cap	1.21B
Revenue (ttm)	519.97M
Net Income (ttm)	-38.10M
Shares Out	562.11M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,426,044
Average Volume	4,036,830
Open	2.130
Previous Close	2.130
Day's Range	2.130 - 2.180
52-Week Range	1.580 - 2.700
Beta	0.01
RSI	57.16
Earnings Date	Apr 16, 2025

About EGX:MCRO

Macro Group Pharmaceuticals (Macro Capital) S.A.E. operates as a cosmeceuticals manufacturing company in Egypt and internationally. It is involved in the production of pharmaceutical and cosmetic products, such as skin care, hair care, oral care, female intimate care, anti-scar, antiseptics, and topical muscle relaxants, as well as flavors, colors, and scents. The company also manufactures solid and liquid soap, herbal medicines, products and extracts, nutritional supplements, baby food, and special food products and distribution. In addition, ...

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2002
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: MCRO

Financial Performance

In 2024, EGX:MCRO's revenue was 519.97 million, a decrease of -1.15% compared to the previous year's 526.01 million. Losses were -38.10 million, -86.03% less than in 2023.